-
FEB 22, 2023
 | 5:30 AM PST
C.E. CREDITS
Labroots and the Drug Discovery planning committee are pleased to announce its 6th annual event in the Drug Discovery & Development Virtual Event Series....
-
FEB 22, 2023 | 7:30 AM
C.E. CREDITS
In general, once a receptor drug target has been validated for the treatment of a particular condition, either a high throughput screen is carried out to identify potential hits, or existing...
FEB 22, 2023 | 6:00 AM
C.E. CREDITS
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious di...